Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 12 clinical trials
Comparison of the Rate of Preoperative Haemoglobin After Administration of Epoetin Alpha Associated With an Oral Medical Supplementation Versus Intravenous Before Surgery of Craniosynostosis at the Child

and compliance with treatment is inconsistent. The aim of this study is to evaluate whether the use of ferric carboxymaltose by injection, which has a much better bioavailability, would make it

  • 24 Jan, 2021
  • 3 locations
Role of Blood Management in Perioperative Outcomes

There is currently limited information regarding the role of blood management in the benign gynecologic population and specifically, in patients who are scheduled to undergo surgery for fibroids and/or abnormal uterine bleeding. A thorough search through PubMed and did not reveal any studies on this issue. In 2019 at …

  • 03 Feb, 2021
  • 1 location
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency

The primary objective of this study is to determine the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM), relative to placebo in the treatment of

b-type natriuretic peptide
cardiac resynchronization therapy
bypass graft
natriuretic peptide
  • 25 Jul, 2021
  • 366 locations
Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation

Iron deficiency is common in kidney transplant recipients and is associated with impaired exercise tolerance and an unfavourable prognosis. This multicentre double-blind, placebo-controlled randomized controlled clinical trial will allow the investigators to analyse the effects of intravenous iron correction with ferric(III) carboxymaltose on exercise tolerance and other parameters, in comparison …

  • 10 May, 2021
  • 2 locations
Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency

The purpose of this study is to better understand how body levels of iron affect the ability to exercise in patients with heart failure. Heart failure is a condition in which abnormal pumping action of the heart reduces the flow of blood to the body. Patients with heart failure may …

  • 27 Feb, 2021
  • 1 location
Randomized Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia

Treatment Phase I and II Primary Objective: To evaluate the efficacy and safety of FCM (750 mg dose x 2) for treatment of Restless Legs Syndrome (RLS) in patients with iron-deficiency anemia (IDA). Long-Term Extension Phase III Primary Objective: To evaluate the duration of effect of prior FCM treatment and …

  • 30 Mar, 2021
  • 8 locations
Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery

This study evaluates the efficacy and safety of single dose preoperative ferric carboxymaltose in the prevention of postoperative infections and blood transfusions in patients scheduled for

arterial disease
percutaneous coronary intervention
mitral valve disease
aortic valve disease
heart disease
  • 26 Apr, 2021
  • 1 location
Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response and Transfusion in Patients With Iron Deficiency Anemia After Off-Pump Coronary Artery Bypass Grafting

. Before surgery, if a patient had iron deficiency anemia, the patient was randomized to receive Ferinject(Ferric carboxymaltose, n=50) or placebo (normal saline, n=50), respectively. A single dose should

off-pump coronary artery bypass
bypass graft
  • 31 May, 2021
  • 1 location
Transfusion Savings in Heart Surgery: Impact of Individual Strategy by Erythropoietin and Metabolic Adjustment (ScvO2)

cardiac surgery patients: optimisation perioperative hemoglobin level by erythropoietin and ferric carboxymaltose (Ferinject) associated with the use of ScV02 to guide perioperative erythrocyte

blood transfusion
red blood cell transfusion
heart surgery
  • 24 Jan, 2021
Intravenous Iron Carboxymaltose Isomaltoside and Oral Iron Sulphate for Postpartum Anemia

reserved for more severe or symptomatic cases. In the last decade, two new intravenous iron compounds have been registered for clinical use: ferric carboxymaltose (Iroprem) and iron isomaltoside (Monofer

  • 26 Jan, 2021
  • 1 location